Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Jun:155:120-125.
doi: 10.1016/j.pediatrneurol.2024.03.013. Epub 2024 Mar 22.

De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia

Collaborators, Affiliations
Multicenter Study

De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia

Lauren A Beslow et al. Pediatr Neurol. 2024 Jun.

Abstract

Background: Approximately 10% of people with hereditary hemorrhagic telangiectasia (HHT) have brain vascular malformations (VMs). Few reports describe de novo brain VM formation. International HHT Guidelines recommend initial brain VM screening upon HHT diagnosis in children but do not address rescreening. We aimed to confirm whether brain VMs can form de novo in patients with HHT.

Methods: The Brain Vascular Malformation Consortium HHT project is a 17-center longitudinal study enrolling patients since 2010. We analyzed the database for de novo VMs defined as those detected (1) on follow-up neuroimaging in a patient without previous brain VMs or (2) in a location distinct from previously identified brain VMs and reported those in whom a de novo VM could be confirmed on central neuroimaging review.

Results: Of 1909 patients enrolled, 409 (21%) had brain VMs. Seven patients were recorded as having de novo brain VMs, and imaging was available for central review in four. We confirmed that three (0.7% of individuals with brain VMs) had de novo brain VMs (two capillary malformations, one brain arteriovenous malformation) with intervals of six, nine, and 13 years from initial imaging. Two with de novo brain VMs were <18 years. The fourth patient, a child, did not have a de novo brain VM but had a radiologically confirmed increase in size of an existing brain arteriovenous malformation.

Conclusions: Brain VMs can, albeit rarely, form de novo in patients with HHT. Given the potential risk of hemorrhage from brain VMs, regular rescreening in patients with HHT may be warranted.

Keywords: Brain arteriovenous malformation; Brain vascular malformation; Capillary malformation; De novo; Hereditary hemorrhagic telangiectasia.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The Brain Vascular Malformation Consortium (U54NS065705) is a part of the NCATS Rare Diseases Clinical Research Network (RDCRN) and is supported by the RDCRNData Management and Coordinating Center (DMCC) (U2CTR002818). RDCRN is an initiative of the Office of Rare Diseases Research (ORDR), NCATS, funded through a collaboration between NCATS and NINDS. L.A.B. was supported by a BVMC fellowship, as part of the funding detailed above. L.A.B. was also supported by the Children's Hospital of Philadelphia Department of Pediatrics Chair's Initiative. M.E.F. was also supported by the Li Ka Shing Knowledge Institute. None of the funding sources directly participated in the study design, data collection, analysis and interpretation of data, writing of the report, or the decision to submit the article for publication.

Figures

Figure 1.
Figure 1.
Conventional angiogram of woman with HHT at age 24 and again at age 37 years demonstrating a de novo brain VM. Coronal (A) and sagittal (B) views with no brain AVM visualized (circles) at age 24 years. Coronal (C) and sagittal (D) views demonstrating a de novo brain AVM in the left paramedian frontal lobe that was not present 13 years earlier (arrows).
Figure 2.
Figure 2.
Brain MRI of a boy with ENG variant at 10 years (A -D) and again at 16 years (E and F) demonstrating a de novo brain capillary malformation. (A-C) Three slices on axial T2-weighted MRI at age 10 years with no evidence of brain capillary malformations. (D) Contrast-enhanced MRI without enhancement at age 10 years. (E) Contrast-enhanced MRI at age 16 years demonstrating enhancement (arrow) in a region that did not previously show enhancement at age 10 years (see D), consistent with a de novo capillary malformation. (F) Axial T2-weighted MRI at age 16 years at the same level as in (A) showing the capillary malformation (arrow) in the left frontal lobe.
Figure 3.
Figure 3.
Brain MRI from an infant (A and B) with a large brain vein of Galen malformation with a de novo capillary malformation in the pons at age 10 years (C and D). (A) Axial time of flight MRI without contrast in infancy with no evidence of pontine capillary malformation. (B) Coronal T2-weighted MRI in infancy with no signal change in the pons. The large vein of Galen malformation is noted (circle). (C) Axial time of flight MRI with contrast at age 10 years with capillary malformation (arrow). (D) Coronal T2-weighted sequence at age 10 years with new signal change in the pons representing a capillary malformation (arrow).
Figure 4.
Figure 4.
Brain MRIs at age 3 years (A and B) and at age 8 years (C and D) showing growth of a left occipital brain AVM with recruitment of new vessels. (A) Axial T2 FLAIR MRI with left mesial occipital brain AVM at age 3 years. (B) Axial time of flight on the same MRI as in (A) demonstrating the left occipital brain AVM. (C) Axial T2 FLAIR MRI at age 8 years in the same child demonstrating enlargement of the brain AVM. (D) Axial time of flight on the same MRI as in (C) showing multiple new vessels recruited to the brain AVM.

Similar articles

Cited by

References

    1. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91(1):66–67. DOI: 10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p - DOI - PubMed
    1. McDonald J, Bayrak-Toydemir P, DeMille D, Wooderchak-Donahue W, Whitehead K. Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2) Genet Med 2020;22(7):1201–1205. DOI: 10.1038/s41436-;020-0775-;8 - DOI - PubMed
    1. Gallione CJ, Richards JA, Letteboer TGW, et al. SMAD4 mutations found in unselected HHT patients. J Med Genet 2006;43(10):793–7. DOI: 10.1136/jmg.2006.041517 - DOI - PMC - PubMed
    1. Brinjikji W, Iyer VN, Wood CP, et al. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg 2017;127(2):302–310. DOI: 10.3171/2016.7.JNS16847 - DOI - PubMed
    1. Hetts SW, Shieh JT, Ohliger MA, et al. Hereditary hemorrhagic telangiectasia: the convergence of genotype, phenotype, and imaging in modern diagnosis and management of a multisystem disease. Radiology 2021;300(1):17–30. DOI: 10.1148/radiol.2021203487 - DOI - PubMed

Publication types

LinkOut - more resources